au.\*:("HARRIS RB")
Results 1 to 16 of 16
Selection :
SYNTHESIS OF TERT-BUTYL AMINOCARBONATE, A NEW TYPE OF COMPOUND THAT CAN BE USED TO ACYLATE AMINESHARRIS RB; WILSON IB.1983; TETRAHEDRON LETT.; ISSN 0040-4039; GBR; DA. 1983; VOL. 24; NO 3; PP. 231-232; BIBL. 3 REF.Article
ANOMALOUS INTERACTION OF 2-THIOPYRIDONE WITH PROTEINS DURING THIOL-DISULFIDE INTERCHANGE REACTIONSHARRIS RB; HODGINS LT.1980; ANAL. BIOCHEM.; ISSN 0003-2697; USA; DA. 1980; VOL. 109; NO 2; PP. 247-249; BIBL. 3 REF.Article
LICHENOID DELAYED HYPERSENSITIVITY REACTIONS IN TATTOOSWINKELMANN RK; HARRIS RB.1979; J. CUTAN. PATHOL.; DNK; DA. 1979; VOL. 6; NO 1; PP. 59-65; BIBL. 38 REF.Article
LUPUS MASTITIS.HARRIS RB; WINKELMANN RK.1978; ARCH. DERMATOL.; U.S.A.; DA. 1978; VOL. 114; NO 3; PP. 410-412; BIBL. 21 REF.Article
GLUTAMIC ACID IS AN ACTIVE SITE RESIDUE OF ANGIOTENSIN I-CONVERTING ENZYME: USE OF THE LOSSEN REARRANGEMENT FOR IDENTIFICATION OF DICARBOXYLIC ACID RESIDUESHARRIS RB; WILSON IB.1983; JOURNAL OF BIOLOGICAL CHEMISTRY; ISSN 0021-9258; USA; DA. 1983; VOL. 258; NO 2; PP. 1357-1362; BIBL. 44 REF.Article
ACTIVE-CONTROL DESIGN CRITERIAHARRIS RB; RICKARD WW.1978; ACTIVE CONTROLS IN AIRCRAFT DESIGN; FRA; NEUILLY-SUR-SEINE: AGARD; DA. 1978; AGARD-AG/234; PP. 2.1-2.13; BIBL. 21 REF.Report
LOMARK: A BIDDING STRATEGY.WADE RL; HARRIS RB.1976; PROC. AMER. SOC. CIV. ENGRS, J. CONSTR. DIV.; U.S.A.; DA. 1976; VOL. 102; NO 1; PP. 197-211; BIBL. 20 REF.Article
PURIFICATION OF HUMAN SERUM ANGIOTENSIN I-CONVERTING ENZYME BY AFFINITY CHROMATOGRAPHYHARRIS RB; OHLSSON JT; WILSON IB et al.1981; ANAL. BIOCHEM.; ISSN 0003-2697; USA; DA. 1981; VOL. 111; NO 2; PP. 227-234; BIBL. 22 REF.Article
DETECTION OF HEPATITIS B SURFACE ANTIGEN IN POTENTIALLY CONTAMINATED HUMAN PLASMA AND PLASMA FRACTIONS.HARRIS RB; SEMAR M; JOHNSON AJ et al.1977; J. LAB. CLIN. MED.; U.S.A.; DA. 1977; VOL. 90; NO 6; PP. 1107-1114; BIBL. 1 P. 1/2Article
PARTIAL PURIFICATION OF BIOLOGICALLY ACTIVE, LOW MOLECULAR WEIGHT, HUMAN ANTIHEMOPHILIC FACTOR FREE OF VON WILLEBRAND FACTOR. II: FURTHER PURIFICATION WITH THIOL-DISULFIDE INTERCHANGE CHROMATOGRAPHY WITH ADDITIONAL EVIDENCE FOR DISULFIDE BONDS SUSCEPTIBLE TO LIMITED REDUCTIONHARRIS RB; JOHNSON AJ; HODGINS LT et al.1981; BIOCHIM. BIOPHYS. ACTA; ISSN 0006-3002; NLD; DA. 1981; VOL. 668; NO 3; PP. 471-480; BIBL. 20 REF.Article
DIFFERENTIATION OF ANTIHEMOPHILIC FACTOR (AHF) AND VON WILLEBRAND FACTOR (VWF) BY THEIR INTERACTION WITH UREA AND SELECTED AMINO ACIDS.HARRIS RB; NEWMAN J; JOHNSON AJ et al.1977; THROMBOSIS RES.; G.B.; DA. 1977; VOL. 11; NO 6; PP. 773-783; BIBL. 1 P. 1/2Article
MOLECULAR WEIGHTS OF ANTIHAEMOPHILIC FACTOR AND VON WILLEBRAND FACTOR PROTEINS IN HUMAN PLASMA.NEWMAN J; HARRIS RB; JOHNSON AJ et al.1976; NATURE; G.B.; DA. 1976; VOL. 263; NO 5578; PP. 612-613; BIBL. 15 REF.Article
INHIBITION AND AFFINITY CHROMATOGRAPHY OF HUMAN SERUM ANGIOTENSIN CONVERTING ENZYME WITH CYSTEINYL-PROLINE DERIVATIVESHARRIS RB; OHLSSON JT; WILSON IB et al.1981; ARCH. BIOCHEM. BIOPHYS.; ISSN 0003-9861; USA; DA. 1981; VOL. 206; NO 1; PP. 105-112; BIBL. 28 REF.Article
PARTIAL PURIFICATION OF BIOLOGICALLY ACTIVE, LOW MOLECULAR WEIGHT, HUMAN ANTIHEMOPHILIC FACTOR FREE OF VON WILLEBRAND FACTOR. I: PARTIAL CHARACTERIZATION AND EVIDENCE FOR DISULFIDE BOND(S) SUSCEPTIBLE TO LIMITED REDUCTIONHARRIS RB; NEWMAN J; JOHNSON AJ et al.1981; BIOCHIM. BIOPHYS. ACTA; ISSN 0006-3002; NLD; DA. 1981; VOL. 668; NO 3; PP. 456-470; BIBL. 51 REF.Article
LYMPHOID FOLLICLES IN SUBCUTANEOUS INFLAMMATORY DISEASEHARRIS RB; DUNCAN SC; ECKER RI et al.1979; ARCH. DERMATOL.; USA; DA. 1979; VOL. 115; NO 4; PP. 442-443; BIBL. 10 REF.Article
TREATMENT OF SCLEROMYXEDEMA WITH MEPHALANHARRIS RB; PERRY HO; KYLE RA et al.1979; ARCH. DERMATOL.; USA; DA. 1979; VOL. 115; NO 3; PP. 295-299; BIBL. 32 REF.Article